News and Commentary
Youtube is allowing creators to address copyright disputes with their published videos by giving an option to simply trim out the disputed content in the video. This may be the first of many updates in 2020 to make copyright rules easier to follow for creators.
Pharmaceutical companies are hiking up prices on just over four hundred drugs in 2020, but only four of them drugs are generic.
Professor Pamela Samuelson writes about the Google v. Oracle case, reviewing recently field amicus curiae briefs. Samuelson gives a good overview of the topic at hand and distinctions in interests between briefs filed focusing on copyrightability, fair use issues, or both.
Apple and Intel have filed a lawsuit citing antitrust violations by a patent troll organization Fortress Investment Group LLC. Mike Masnick at Techdirt writes on the interesting nature of this complaint.
Russian academic publishing has taken a serious hit as hundreds of papers are being retracted in academic journals for plagiarism, self-plagiarism, and gift authorship.
Thomas Cotter blogs about the Inventor Rights Act of 2019 and why it’s a bad idea with thankfully little chance of passing. If the patent system exists to encourage and reward innovation, providing another venue for rent-seeking is hardly in line with that ethos.
Qualcomm makes some peculiar arguments in a reply brief per its ongoing case with the FTC.
EFF’s Alex Moss reviews new introduced legislation that gives Customs and Border Protection the power to seize imports they think violate design patents. This would make the CBP able to enforce design patents at the border while “prior art” or related products prior to the patent, go unconsidered. Such a policy is likely to worsen the state of affairs for both innovators and consumers.
Many are aware Louisa May Alcott’s novel Little Women has been adopted into another movie version, but you might not know how Alcott’s novel maintained copyright for 56 years after the first filing in a local federal court.
New Research
A paper at NBER discusses the spillovers of defense R&D funding, finding some of cross-country differences in private R&D investment among countries are explained by differences in defense R&D spending among countries. The authors provide a rundown of the paper here.
Loading...